tirzepatide surmount 4 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Diabetes Dialogue: SURMOUNT-3 and -4

E., Magyar, P

PMID 19860577

There is a broad consensus that GLP-1 receptor agonists have transformed the management of T2D, obesity, and related morbidity and have been associated with reduced progression of renal disease, cardiovascular disease, and mortality in people with metabolic disorders

Safe Timing and Dosing of Magnesium With Semaglutide The safest approach is to separate magnesium supplementation from your semaglutide injection or oral dose by at least 24 hours

She highlighted prescriber-directed medication adjustmentssuch as slow dose escalation, use of the lowest therapeutic dose, microdosing/intermediate dosing, and supportive measures, such as anti-emetics/prokineticsas effective strategies for side-effect management

2005 May;4(2):288-314